Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Rallybio Corp
13G/A
RLYB · 75120L209
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 0% | ||||
| Bihua Chen | 0% | ||||
|
Rapport Therapeutics, Inc.
13G/A
RAPP · 75383L102
|
5.6% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 5.6% | ||||
| Bihua Chen | 5.6% | ||||
|
Quince Therapeutics, Inc.
13G
IRLA · 22053A305
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 10.0% | ||||
| Bihua Chen | 10.0% | ||||
|
MoonLake Immunotherapeutics
13G/A
MLTX · 61559X104
|
4.4% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 4.4% | ||||
| Bihua Chen | 4.4% | ||||
|
iBio, Inc.
13G/A
IBIO · 451033708
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 10.0% | ||||
| Bihua Chen | 10.0% | ||||
|
EyePoint, Inc.
13G/A
EYPT · 30233G209
|
8.4% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 8.4% | ||||
| Bihua Chen | 8.4% | ||||
|
Bright Minds Biosciences Inc.
13G/A
DRUG · 10919W405
|
9.2% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 9.2% | ||||
| Bihua Chen | 9.2% | ||||
|
Cabaletta Bio, Inc.
13G/A
CABA · 12674W109
|
6.0% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 6.0% | ||||
| Bihua Chen | 6.0% | ||||
|
BioAge Labs, Inc.
13G/A
BIOA · 09077V100
|
5.4% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 5.4% | ||||
| Bihua Chen | 5.4% | ||||
|
Adlai Nortye Ltd.
13G/A
ANL · 00704R109
|
6.8% |
8/14/2026
Event 6/30/2026
|
|||
| Cormorant Asset Management, LP | 6.8% | ||||
| Bihua Chen | 6.8% | ||||
|
BlossomHill Therapeutics, Inc.
13D
BLSM · 095130100
|
11.8% |
8/13/2026
Event 8/6/2026
|
|||
| Cormorant Global Healthcare Master Fund, LP | 3.1% | ||||
| Cormorant Global Healthcare GP, LLC | 3.1% | ||||
| Cormorant Private Healthcare Fund III, LP | 4.0% | ||||
| Cormorant Private Healthcare GP III, LLC | 4.0% | ||||
| Cormorant Private Healthcare Fund V, LP | 3.4% | ||||
| Cormorant Private Healthcare GP V, LLC | 3.4% | ||||
| Cormorant Private Healthcare Fund VI, LP | 1.2% | ||||
| Cormorant Private Healthcare GP VI, LLC | 1.2% | ||||
| Cormorant Asset Management, LP | 11.8% | ||||
| Chen Bihua | 11.8% | ||||
|
Agomab Therapeutics NV
13G
AGMB · 00860C102
|
5.0% |
5/15/2026
Event 3/31/2026
|
|||
| Cormorant Asset Management, LP | 5.0% | ||||
| Bihua Chen | 5.0% | ||||
|
enGene Holdings Inc.
13G/A
ENGN · 29286M105
|
0% |
5/15/2026
Event 3/31/2026
|
|||
| Cormorant Asset Management, LP | 0% | ||||
| Bihua Chen | 0% | ||||
|
Corbus Pharmaceuticals Holdings, Inc.
13G/A
CRBP · 21833P301
|
13.4% |
12/15/2025
Event 12/11/2025
|
|||
| Cormorant Asset Management, LP | 13.4% | ||||
| Chen Bihua | 13.4% | ||||
|
VYNE Therapeutics Inc.
13G/A
VYNE · 92941V308
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Cormorant Asset Management, LP | 0% | ||||
| Bihua Chen | 0% | ||||
|
Praxis Precision Medicines, Inc.
13G/A
PRAX · 74006W207
|
4.0% |
11/14/2025
Event 9/30/2025
|
|||
| Cormorant Asset Management, LP | 4.0% | ||||
| Bihua Chen | 4.0% | ||||
|
KALA BIO, Inc.
13G/A
KALA · 483119202
|
0% |
11/14/2025
Event 9/30/2025
|
|||
| Cormorant Asset Management, LP | 0% | ||||
| Bihua Chen | 0% | ||||
|
Biomea Fusion, Inc.
13D/A
BMEA · 09077A106
|
1.5% |
10/24/2025
Event 10/22/2025
|
|||
| Cormorant Global Healthcare Master Fund, LP | 0.7% | ||||
| Cormorant Global Healthcare GP, LLC | 0.7% | ||||
| Cormorant Private Healthcare Fund III LP | 0.7% | ||||
| Cormorant Private Healthcare GP III, LLC | 0.7% | ||||
| Cormorant Asset Management, LP | 1.4% | ||||
| Chen Bihua | 1.5% | ||||
|
OnKure Therapeutics, Inc.
13G/A
OKUR · 68277Q105
|
0% |
5/19/2025
Event 5/15/2025
|
|||
| Cormorant Asset Management, LP | 0% | ||||
| Bihua Chen | 0% | ||||
|
CARGO Therapeutics, Inc.
13G
CRGX · 14179K101
|
7.3% |
5/15/2025
Event 3/31/2025
|
|||
| Cormorant Asset Management, LP | 7.3% | ||||
| Bihua Chen | 7.3% | ||||